Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Zlatuše Křístková"'
Autor:
Tomas Milota, Jana Hurnakova, Karel Pavelka, Zlatuse Kristkova, Lucie Nekvindova, Rudolf Horvath
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 14 (2022)
Introduction: The administration of biologic disease-modifying antirheumatic drugs, including tumor necrosis factor (TNF)-α inhibitors, is observed to interfere with the disease activity and progression. In this study, we aimed to assess the effecti
Externí odkaz:
https://doaj.org/article/51fdc92e7cbb480c9fe02c0414d1184c
Autor:
Lucie Nekvindová, Jiří Vencovský, Karel Pavelka, Pavel Horák, Zlatuše Křístková, Jakub Závada
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-10 (2021)
Abstract Background Treat-to-target (T2T) is a widely accepted strategy for patients with rheumatoid arthritis (RA). It recommends attaining a goal of at least low disease activity (LDA) within 6 months; otherwise, the current therapy should be modif
Externí odkaz:
https://doaj.org/article/cdac019808f04a84af01b113280dc57e
Autor:
Martina, Skácelová, Lucie, Nekvindová, Heřman, Mann, Jakub, Závada, Zlatuše, Křístková, Jiří, Vencovský, Karel, Pavelka, Pavel, Horák
Publikováno v:
Rheumatology International. 42:803-814
The study aimed to compare treatment retention for first-line TNF inhibitor (TNFi) in the ATTRA registry patients receiving either combination with conventional synthetic DMARDs or TNFi as monotherapy. A retrospective multicenter study analyzed data
Autor:
Nekvindová, Lucie, Jiří Vencovský, Pavelka, Karel, Horák, Pavel, Zlatuše Křístková, Závada, Jakub
Additional file 6: Supplementary Figure 2. Disease activity according to DAS28-ESR after three months of treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ebf2850904794e22d563fdfe3a78a81
Autor:
Nekvindová, Lucie, Jiří Vencovský, Pavelka, Karel, Horák, Pavel, Zlatuše Křístková, Závada, Jakub
Additional file 3: Supplementary Table 3. Comparison of differences in parameters from month 6 to 12 between cohort C3 and C4.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::348ce7d065fe89f01ce61fe6f235723b
Autor:
Nekvindová, Lucie, Jiří Vencovský, Pavelka, Karel, Horák, Pavel, Zlatuše Křístková, Závada, Jakub
Additional file 7: Supplementary Figure 3. Propensity score densities of cohorts C3 and C4 before and after matching.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d7a031b1299011228d10554ae589bcb
Autor:
Nekvindová, Lucie, Jiří Vencovský, Pavelka, Karel, Horák, Pavel, Zlatuše Křístková, Závada, Jakub
Additional file 1: Supplementary Table 1. Additional baseline characteristics of patients in cohorts C1–C4 (N=1275).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcea0f1a666265f8de27060fafa785c5
Autor:
Nekvindová, Lucie, Jiří Vencovský, Pavelka, Karel, Horák, Pavel, Zlatuše Křístková, Závada, Jakub
Additional file 2: Supplementary Table 2. Changes in comedication with glucocorticoids and methotrexate during the first year in cohorts C1–C4.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c05fc74021dfa6099ab51f30dbb824c3
Autor:
Nekvindová, Lucie, Jiří Vencovský, Pavelka, Karel, Horák, Pavel, Zlatuše Křístková, Závada, Jakub
Additional file 4: Supplementary Table 4. Results of logistic regression with outcome DAS28-ESR ≤ 3.2 for C3 vs C4.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c981118da4d837d22338cefa5e56b05
Autor:
Lucie Nekvindova, Jiří Vencovský, Karel Pavelka, Pavel Horák, Zlatuše Křístková, Jakub Závada
Background: Treat-to-target (T2T) is a widely accepted strategy for patients with rheumatoid arthritis (RA). It recommends attaining a goal of at least low disease activity (LDA) within six months; otherwise, the current therapy should be modified. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9abb3983f8e22c95b1d45876bba23b48
https://doi.org/10.21203/rs.3.rs-76194/v1
https://doi.org/10.21203/rs.3.rs-76194/v1